Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Understand that: benefits are uncertain risks are unknown product quality varies We encourage patients to keep us informed so we can support your care safely
Orders are limited to laboratory and research customers aged 21 or over
Large-scale human clinical trials have not yet been completed
REDEFINE 2 (obesity with type 2 diabetes) A phase 3a, 68-week, double-blind, placebo-controlled trial across 12 countries (NCT05394519 [11] ) in 1,206 adults with BMI 27, HbA 1c 710%, and type 2 diabetes, randomised 3:1 to CagriSema 2.4/2.4 mg (n=904) or placebo (n=302)
This step is especially important when peptides will be combined or drawn frequently
US$ 24.54
US$ 20.02
US$ 26.91
US$ 28.21
US$ 28.15
US$ 24.06
US$ 19.99
US$ 26.73
